Concepedia

Daniel Hunziker

DH

Statistics

Publications

16

Citations

1.4K

H-Index

14

Active since

1992

Affiliations

Roche (Switzerland)(Current)

Stanford University

Nebraska Medical Center

University of Nebraska Medical Center

Monash University

Daniel Hunziker is an author at Roche (Switzerland) specializing in drug discovery, pharmacy, and pharmacology.

Publications per year

1992–2022

16

Publications

16

Identification of an antimalarial synthetic trioxolane drug development candidate

Jonathan L. Vennerstrom, Sarah Arbe‐Barnes, Reto Brun et al. · Nature · 2004 · 617 citations

, , +10

On the Mechanisms of Enantioselective Reactions Using α,α,α′,α′ ‐Tetraaryl‐1,3‐dioxolane‐4,5‐dimethanol(TADDOL)‐Derived Titanates: Differences between <i>C</i><sub>2</sub>‐ and <i>C</i><sub>1</sub>‐symmetrical TADDOLs – facts, implications and generalizations

Dieter Seebàch, Dietmar A. Plattner, Albert K. Beck et al. · Helvetica Chimica Acta · 1992 · 227 citations

, , +12

Mechanism and specificity of the terminal thioesterase domain from the erythromycin polyketide synthase

Rajesh S. Gokhale, Daniel Hunziker, David E. Cane et al. · Chemistry & Biology · 1999 · 155 citations

, , +14

Role of the autotaxin-lysophosphatidic acid axis in glaucoma, aqueous humor drainage and fibrogenic activity

Leona Ho, Anja Osterwald, Iris Ruf et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2019 · 43 citations · Full text

, , +16

Primer Unit Specificity in Rifamycin Biosynthesis Principally Resides in the Later Stages of the Biosynthetic Pathway

Daniel Hunziker, Tin‐Wein Yu, C. Richard Hutchinson et al. · Journal of the American Chemical Society · 1998 · 42 citations

, , +5

1–5 of 16